StockData
Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (LH) stock

LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$372.46+1.98 (+0.53%)

Close on Nov 16, 2026Market cap $30.24BP/E 30.6Yield 0.77%

Labcorp total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Labcorp's total debt was $5.85B at Sep 30, 2026. For fiscal 2025 it was $5.58B, down 11.8% from the year before. Over ten years it grew -1.3% a year on average. The highest annual figure on record is $6.76B in fiscal 2017.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.58B-11.8%
FY2024Dec 31, 2024$6.33B+25.3%
FY2023Dec 31, 2023$5.05B-5.3%
FY2022Dec 31, 2022$5.34B-1.4%
FY2021Dec 31, 2021$5.42B-6.5%
FY2020Dec 31, 2020$5.80B-6.6%
FY2019Dec 31, 2019$6.21B+3.4%
FY2018Dec 31, 2018$6.00B-11.3%
FY2017Dec 31, 2017$6.76B+15.6%
FY2016Dec 31, 2016$5.85B-8.1%
FY2015Dec 31, 2015$6.36B+110.1%
FY2014Dec 31, 2014$3.03B+1.0%
FY2013Dec 31, 2013$3.00B+13.0%
FY2012Dec 31, 2012$2.66B+19.5%
FY2011Dec 31, 2011$2.22B+1.5%
FY2010Dec 31, 2010$2.19B+56.9%
FY2009Dec 31, 2009$1.39B-19.0%
FY2008Dec 31, 2008$1.72B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$5.85B+15.1%
Q2 FY2026Jun 30, 2026$5.86B+15.4%
Q1 FY2026Mar 31, 2026$6.33B+13.7%
Q4 FY2025Dec 31, 2025$5.58B-11.8%
Q3 FY2025Sep 30, 2025$5.08B-5.0%
Q2 FY2025Jun 30, 2025$5.08B+66.6%
Q1 FY2025Mar 31, 2025$5.57B+82.7%
Q4 FY2024Dec 31, 2024$6.33B+25.3%
Q3 FY2024Sep 30, 2024$5.35B+20.9%
Q2 FY2024Jun 30, 2024$3.05B-39.6%
Q1 FY2024Mar 31, 2024$3.05B-39.7%
Q4 FY2023Dec 31, 2023$5.05B-5.3%
Q3 FY2023Sep 30, 2023$4.43B-17.0%
Q2 FY2023Jun 30, 2023$5.04B-5.9%
Q1 FY2023Mar 31, 2023$5.05B-6.1%
Q4 FY2022Dec 31, 2022$5.34B-1.4%
Q3 FY2022Sep 30, 2022$5.33B-1.5%
Q2 FY2022Jun 30, 2022$5.36B-1.1%
Q1 FY2022Mar 31, 2022$5.38B+9.4%
Q4 FY2021Dec 31, 2021$5.42B-6.5%
Q3 FY2021Sep 30, 2021$5.42B-6.5%
Q2 FY2021Jun 30, 2021$5.42B-12.6%
Q1 FY2021Mar 31, 2021$4.92B-20.7%
Q4 FY2020Dec 31, 2020$5.80B-6.6%
Q3 FY2020Sep 30, 2020$5.79B-12.3%
Q2 FY2020Jun 30, 2020$6.21B-6.5%
Q1 FY2020Mar 31, 2020$6.21B+3.5%
Q4 FY2019Dec 31, 2019$6.21B+3.4%
Q3 FY2019Sep 30, 2019$6.60B+2.2%
Q2 FY2019Jun 30, 2019$6.64B+2.8%
Q1 FY2019Mar 31, 2019$6.00B-11.5%
Q4 FY2018Dec 31, 2018$6.00B-11.3%
Q3 FY2018Sep 30, 2018$6.46B-10.5%
Q2 FY2018Jun 30, 2018$6.46B+5.4%
Q1 FY2018Mar 31, 2018$6.78B+14.5%
Q4 FY2017Dec 31, 2017$6.76B+15.6%
Q3 FY2017Sep 30, 2017$7.22B–
Q2 FY2017Jun 30, 2017$6.13B–
Q1 FY2017Mar 31, 2017$5.92B–
Q4 FY2016Dec 31, 2016$5.85B–

More Labcorp figures

See a number that looks wrong?